AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
ANAVEX LIFE SCIENCES CORP.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026
$1.25−0.06 (-4.58%)
Close on Oct 19, 2026
- Market cap
- $116.12B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Anavex Life Sciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 20, 2026 | Oct 20, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 15, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2026 | Sep 9, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2026 | Sep 2, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Aug 28, 2026 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Dec 31, 2025 | Aug 28, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | Sep 30, 2025 | Aug 28, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 25, 2026 | Aug 25, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 17, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2026 | Aug 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 20, 2026 | Jul 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 20, 2026 | May 22, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2026 | Feb 25, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 9, 2026 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2025 | Nov 25, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 25, 2025 | Nov 25, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 25, 2025 | Jul 28, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 3, 2025 | Jul 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 25, 2025 | Apr 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 12, 2025 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2024 | Dec 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2024 | Jul 30, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2024 | Jun 21, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 6, 2024 | May 6, 2024 | SEC EDGAR |